Microcavity arrays as an in vitro model system of the bone marrow niche for hematopoietic stem cells
- 874 Downloads
In previous studies human mesenchymal stromal cells (MSCs) maintained the “stemness” of human hematopoietic progenitor cells (HPCs) through direct cell–cell contact in two-dimensional co-culture systems. We establish a three-dimensional (3D) co-culture system based on a custom-made chip, the 3D-KITChip, as an in vitro model system of the human hematopoietic stem cell niche. This array of up to 625 microcavities, with 300 μm size in each orientation, was inserted into a microfluidic bioreactor. The microcavities of the 3D-KITChip were inoculated with human bone marrow MSCs together with umbilical cord blood HPCs. MSCs used the microcavities as a scaffold to build a complex 3D mesh. HPCs were distributed three-dimensionally inside this MSC network and formed ß-catenin- and N-cadherin-based intercellular junctions to the surrounding MSCs. Using RT2-PCR and western blots, we demonstrate that a proportion of HPCs maintained the expression of CD34 throughout a culture period of 14 days. In colony-forming unit assays, the hematopoietic stem cell plasticity remained similar after 14 days of bioreactor co-culture, whereas monolayer co-cultures showed increasing signs of HPC differentiation and loss of stemness. These data support the notion that the 3D microenvironment created within the microcavity array preserves vital stem cell functions of HPCs more efficiently than conventional co-culture systems.
KeywordsHematopoietic progenitor cells Mesenchymal stromal cells Stem cell niche Microcavity array Bioreactor
The authors thank Angela Lenze and Anke Diehlmann for isolation and preparation of HPCs and MSCs, as well as David Thiele and Anke Dech for technical assistance. We also thank Siegfried Horn, Jörg Bohn and Hartmut Gutzeit for the construction and manufacturing of the bioreactors and periphery. This work was supported by the German Ministry of Education and Research (BMBF) within the supporting program “Cell Based Regenerative Medicine” (START-MSC2; funding code 01GN0940 to ADH and PW) and within the collaborative research project “Systems Biology of Erythropoietin” (SBEpo; funding code 0316182D to ADH and PW). This work was also supported by the HEiKA Research Alliance (funding to EG and PW) and the German Research Foundation DFG (SFB 873, funding to ADH and PW). The authors also thank the Karlsruhe Nano and Micro Facility (KNMF) for the support of the project.
We acknowledge the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf ) of KIT for access to instruments at their laboratories and we would like to thank Dr. Matthias Worgull and his team for the manufacturing of the KITChips.
Compliance with ethical standards
The first author and all co-authors confirm that there are no relevant conflicts of interest to disclose, except for the following:
Patrick Wuchter: Honoraria and Membership on Advisory Boards of Sanofi-Aventis. Travel grants from Hexal AG.
Anthony D. Ho: Research funding from and Membership on Advisory Board of Genzyme/Sanofi-Aventis.
- Bauer N, Wilsch-Brauninger M, Karbanova J, Fonseca AV, Strauss D, Freund D, Thiele C, Huttner WB, Bornhauser M, Corbeil D (2011) Haematopoietic stem cell differentiation promotes the release of prominin-1/CD133-containing membrane vesicles--a role of the endocytic-exocytic pathway. EMBO Mol Med 3:398–409CrossRefPubMedPubMedCentralGoogle Scholar
- Dang LT, Feric NT, Laschinger C, Chang WY, Zhang B, Wood GA, Stanford WL, Radisic M (2014) Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS. Biomaterials 35:7786–7799CrossRefPubMedPubMedCentralGoogle Scholar
- Dexter TM, Laijtha LG (1975) Proliferation of hemopoietic stem cells and development of potentially leukemic cells in vitro. Bibl Haematol 1975 Oct (43):1–5Google Scholar
- Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. Int Soc Cell Ther Pos Statement Cytotherapy 8:315–317Google Scholar
- Giselbrecht S, Gottwald, E., Truckenmüller, R., Trautmann, C., Welle, A., Guber, A., Saile, V., Gietzelt, T., Weibezahn, K.-F. (2008) Microfabrication of chip-sized scaffolds for the three-dimensional cell cultivation J Vis Exp 15:e699Google Scholar
- Gottwald E, Giselbrecht S, Augspurger C, Lahni B, Dambrowsky N, Truckenmüller R, Piotter V, Gietzelt T, Wendt O, Pfleging W, Welle A, Rolletschek A, Wobus AM, Weibezahn K-F (2007a) A chip-based platform for the in vitro generation of tissues in three-dimensional organization. Lab Chip 7:777–785CrossRefPubMedGoogle Scholar
- Gottwald E, Giselbrecht S, Lahni B, Hiebl B, Weibezahn K-F (2007b) Cell Chip-basierte Bioreaktoren für die extrakorporale Organunterstützung. Galvanotechnik 4:974–978Google Scholar
- Gottwald E. LB, Thiele D., Giselbrecht S., Welle A., Weibezahn K.F. (2008) Chip-based three-dimensional cell culture in perfused micro-bioreactors. J Vis Exp 15:e564Google Scholar
- Hanke M, Hoffmann I, Christophis C, Schubert M, Hoang VT, Zepeda-Moreno A, Baran N, Eckstein V, Wuchter P, Rosenhahn A, Ho AD (2014) Differences between healthy hematopoietic progenitors and leukemia cells with respect to CD44 mediated rolling versus adherence behavior on hyaluronic acid coated surfaces. Biomaterials 35:1411–1419CrossRefPubMedGoogle Scholar
- Mohty M, Hubel K, Kroger N, Aljurf M, Apperley J, Basak GW, Bazarbachi A, Douglas K, Gabriel I, Garderet L, Geraldes C, Jaksic O, Kattan MW, Koristek Z, Lanza F, Lemoli RM, Mendeleeva L, Mikala G, Mikhailova N, Nagler A, Schouten HC, Selleslag D, Suciu S, Sureda A, Worel N, Wuchter P, Chabannon C, Duarte RF (2014) Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 49:865–872CrossRefPubMedGoogle Scholar
- Schajnovitz A, Itkin T, D'Uva G, Kalinkovich A, Golan K, Ludin A, Cohen D, Shulman Z, Avigdor A, Nagler A, Kollet O, Seger R, Lapidot T (2011) CXCL12 secretion by bone marrow stromal cells is dependent on cell contact and mediated by connexin-43 and connexin-45 gap junctions. Nat Immunol 12:391–398CrossRefPubMedGoogle Scholar
- Spiller KL, Nassiri S, Witherel CE, Anfang RR, Ng J, Nakazawa KR, Yu T, Vunjak-Novakovic G (2015) Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. Biomaterials 37:194–207CrossRefPubMedPubMedCentralGoogle Scholar
- Wuchter P, Boda-Heggemann J, Straub BK, Grund C, Kuhn C, Krause U, Seckinger A, Peitsch WK, Spring H, Ho AD, Franke WW (2007) Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells. Cell Tissue Res 328:499–514CrossRefPubMedGoogle Scholar
- Wuchter P, Leinweber C, Saffrich R, Hanke M, Eckstein V, Ho AD, Grunze M, Rosenhahn A (2014) Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells. Cell Tissue Res 355:315–326CrossRefPubMedGoogle Scholar